Join Dr. Matthew Smeltzer, Associate Professor at the University of Memphis and 2024 Biomarker Survey Steering Committee Member, in shaping the future of lung cancer care. Take just 10 minutes to share your valuable insights in the ongoing international survey conducted by IASLC on biomarker testing practices. Your contribution as a researcher, clinician, or advocate is crucial in improving patient outcomes. Take action today and make a difference!